Implicate and explicate order

ILLUMINATE Film Festival Announces Key Partnership with the Holomovement

Retrieved on: 
Friday, January 19, 2024
Partnership, Festival, Consciousness, Implicate and explicate order, Physics, Storytelling, Life, Film industry

SANTA BARBARA, Calif., Jan. 19, 2024 /PRNewswire-PRWeb/ -- ILLUMINATE Film Festival, the world's leading festival for evolutionary cinema, announces a key creative partnership with the Holomovement for its 2024 event April 5 - 14, in Santa Barbara, CA and globally online. The theme for the Festival will be "Movies Make Movements Happen," bridging ILLUMINATE's mission to elevate human consciousness through cinema, with the Holomovement's work catalyzing a critical mass of transformative action for the greatest good.

Key Points: 
  • ILLUMINATE Film Festival, the world's leading festival for evolutionary cinema, announces a key creative partnership with the Holomovement, a network of change agents catalyzing a critical mass of transformative action for the greatest good.
  • SANTA BARBARA, Calif., Jan. 19, 2024 /PRNewswire-PRWeb/ -- ILLUMINATE Film Festival , the world's leading festival for evolutionary cinema, announces a key creative partnership with the Holomovement for its 2024 event April 5 - 14, in Santa Barbara, CA and globally online.
  • "Storytelling and impact unite in this revolutionary partnership," says Holomovement Core Synergist Mariko Pitts, "through which the ILLUMINATE Film Festival and the Holomovement will fulfill our collective mission of creating a world that works for all."
  • This partnership will support a HoloMovie Award with a $5,000 cash prize and a free virtual program about "Catalyzing the Holomovement'' serving as a centerpiece within ILLUMINATE's online festival programming.

Implicity Continues Rapid Growth and Expansion with Hiring of Two New Senior Leaders

Retrieved on: 
Wednesday, September 28, 2022
Adoption, Idealized cognitive model, Communication, Algorithm, Implantable loop recorder, Efficiency, Workload, FDA, No. 166 Squadron RAF, Company, Heart, Medtech, Growth, European Heart Journal, Review, Philips, Industry, Heart failure, Head, Patient, CEO, Technology, Medtronic, Cardiology, ECG, St. Jude Medical, Research, Marketing, Awareness, RPM, Medical device, Electrophysiology, Implicate and explicate order

CAMBRIDGE, Mass., Sept. 28, 2022 /PRNewswire/ -- Implicity®, a leader in remote patient monitoring and cardiac data management solutions, announced its continued growth with the appointment of two new senior-level executives. Vanessa Joyce was named the Company's new Vice President of Sales for North America, and Megan Grosz was appointed Global Head of Marketing and Communications.

Key Points: 
  • Both Vanessa and Megan bring a wealth of industry knowledge to support our rapid global expansion, particularly in the U.S.where we see a dramatic rise in remote patient monitoring," said Dr. Arnaud Rosier, Electrophysiologist, CEO, and Co-founder of Implicity.
  • Vanessa Joyce comes to Implicity with more than 30 years of experience in MedTech marketing and clinical aspects ofthe Cardiac, Heart Failure, and Electrophysiology industries.
  • "I'm excited to apply my expertise and experience to establish Implicity as the primary CIED remote monitoring software solution," said Joyce.
  • Implicity proudly protects more than 70,000 patients in more than 100 medical facilities across the United States and Europe.

Implicity Receives FDA Clearance for AI-Powered ECG Analyzer for Implantable Loop Recorders

Retrieved on: 
Thursday, December 16, 2021
Lazarus, ILR, Cardiac electrophysiology, Arrhythmia, FDA, Solution, Implantable loop recorder, Cleveland, Algorithm, ECG, European Heart Journal, Health, XT, Noise, Fortis Healthcare, National Association Medical Staff Services, Cleveland Clinic, Ventricular fibrillation, Medtronic, CEO, Research, No. 166 Squadron RAF, Workload, Patient, Artificial intelligence, Degenerative disease, MD, LINQ, Technology, Cardiology, Medical device, Pharmaceutical industry, Implicate and explicate order

CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).

Key Points: 
  • CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ -- Implicity , a leader in remote patient monitoring and cardiac data management solutions, today announced FDA clearance for a novel medicalalgorithm that analyzes ECG data from Implantable Loop Recorders (ILRs).
  • The newly 510(k) cleared ILR ECG Analyzer is an algorithm based on artificial intelligence, representing a breakthrough innovation in the cardiology sector.
  • "This is an important step for Implicity as we expand in the US market," said Dr. Arnaud Rosier, CEO and founder of Implicity.
  • "With FDA clearance, our AI product can now be used in combination with implantable loop recorders to improve arrhythmia detection and help electrophysiologists and their teams avoid wasting time reviewing non-actionable events."